A. Herskowitz, CARDIOMYOPATHY AND OTHER SYMPTOMATIC HEART-DISEASES ASSOCIATED WITH HIV-INFECTION, Current opinion in cardiology, 11(3), 1996, pp. 325-331
Approximately 14 million persons worldwide are estimated to be infecte
d with HIV-1. As more effective therapies have produced longer surviva
l times for HIV-infected patients, new complications of late-stage HIV
infection including HIV-related heart disease have emerged. The most
common and life-threatening cardiovascular complication of HIV infecti
on is the development of primary heart muscle disease associated with
severe global left ventricular dysfunction (also termed cardiomyopathy
). Other less common forms of symptomatic heart disease in HIV-1-infec
ted patients are pericardial effusion with cardiac tamponade, high-gra
de arrhythmia with sudden cardiac death, and systemic embolization cau
sed by nonbacterial thrombotic endocarditis or infective endocarditis.
The demographic and clinical characteristics of HIV-infected patients
who develop cardiomyopathy as well as potential enhancing risk factor
s are as yet poorly characterized. This review briefly describes the v
arious presentations and potential causes of symptomatic HIV-related h
eart disease and discusses the challenge facing clinicians who evaluat
e HIV-infected patients presenting with serious cardiac manifestations
of their disease.